Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

ClinicalTrials.gov ID: NCT00332826

Public ClinicalTrials.gov record NCT00332826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 7:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes mellitus and concurrent asthma.

Study identification

NCT ID
NCT00332826
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mannkind Corporation
Industry
Enrollment
3 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Sep 30, 2007
Completion
Sep 30, 2007
Last update posted
May 3, 2012

2006 – 2007

United States locations

U.S. sites
25
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85023
Northwest Medical Center Phoenix Arizona 85029
Premiere Pharmaceutical Research LLC Tempe Arizona 85282
Canyon Internal Medicine Tucson Arizona 85712
Associated Pharmaceutical Research Center Inc Buena Park California 90620
Family Medical Center Foothill Ranch California 92610
Health Care Partners Medical Group Long Beach California 90806
Golden Pine Clinical Research Long Beach California 90807
Keck USC School of Medicine Los Angeles California 90033
Pinaccle Trials Inc (SMO) Atlanta Georgia 30329
Executive Health and Research Associates Inc Atlanta Georgia 30342
Atlanta Pharmaceutical Research Center Dunwoody Georgia 30338
Southeastern Endocrine & Diabetes Roswell Georgia 30076
Cedar-Crosse Research Center Chicago Illinois 60607
Franklin Square Hospital Baltimore Maryland 21237
Healthcare Research Florissant Missouri 63031
MedEx Healthcare Research Inc(009) St Louis Missouri 63117
Billings Clinic Research Division Billings Montana 59101
Your Doctors Care Hillsborough New Jersey 08844
Hopewell Valley Family Medicine PA Trenton New Jersey 08618
Eastside Comprehensive Medical Center New York New York 10021
Carolinas Research Concord North Carolina 28025
Cleveland Clinic Dept of Endocrinology Cleveland Ohio 44195
Diabetes & Glandular Disease Research Assoc PA San Antonio Texas 78229
McLennan County Medical Education and Research Foundation Waco Texas 76707

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00332826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2012 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00332826 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →